Mass General / North Shore Can — Boston, Massachusetts

Mass General / North Shore Can is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Mass General / North Shore Can has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General / North Shore Can?

Mass General / North Shore Can has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General / North Shore Can conducted?

Mass General / North Shore Can has 1 clinical trials on record, with 1 currently active. Their work covers Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer.

Is Mass General / North Shore Can accredited by Crixeo Health?

Mass General / North Shore Can has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General / North Shore Can?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.